Journal article Open Access
Calaras, Diana;
Rusu, Doina;
David, Aliona;
Botnaru, Victor
<?xml version='1.0' encoding='utf-8'?> <rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:adms="http://www.w3.org/ns/adms#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dct="http://purl.org/dc/terms/" xmlns:dctype="http://purl.org/dc/dcmitype/" xmlns:dcat="http://www.w3.org/ns/dcat#" xmlns:duv="http://www.w3.org/ns/duv#" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:frapo="http://purl.org/cerif/frapo/" xmlns:geo="http://www.w3.org/2003/01/geo/wgs84_pos#" xmlns:gsp="http://www.opengis.net/ont/geosparql#" xmlns:locn="http://www.w3.org/ns/locn#" xmlns:org="http://www.w3.org/ns/org#" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:prov="http://www.w3.org/ns/prov#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:schema="http://schema.org/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:vcard="http://www.w3.org/2006/vcard/ns#" xmlns:wdrs="http://www.w3.org/2007/05/powder-s#"> <rdf:Description rdf:about="https://doi.org/10.5281/zenodo.4018896"> <dct:identifier rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://doi.org/10.5281/zenodo.4018896</dct:identifier> <foaf:page rdf:resource="https://doi.org/10.5281/zenodo.4018896"/> <dct:creator> <rdf:Description rdf:about="http://orcid.org/0000-0002-8963-459X"> <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/> <dct:identifier rdf:datatype="http://www.w3.org/2001/XMLSchema#string">0000-0002-8963-459X</dct:identifier> <foaf:name>Calaras, Diana</foaf:name> <foaf:givenName>Diana</foaf:givenName> <foaf:familyName>Calaras</foaf:familyName> <org:memberOf> <foaf:Organization> <foaf:name>Nicolae Testemitanu State University of Medicine and Pharmacy Chisinau, the Republic of Moldova</foaf:name> </foaf:Organization> </org:memberOf> </rdf:Description> </dct:creator> <dct:creator> <rdf:Description rdf:about="http://orcid.org/0000-0003-3029-5025"> <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/> <dct:identifier rdf:datatype="http://www.w3.org/2001/XMLSchema#string">0000-0003-3029-5025</dct:identifier> <foaf:name>Rusu, Doina</foaf:name> <foaf:givenName>Doina</foaf:givenName> <foaf:familyName>Rusu</foaf:familyName> <org:memberOf> <foaf:Organization> <foaf:name>Nicolae Testemitanu State University of Medicine and Pharmacy Chisinau, the Republic of Moldova</foaf:name> </foaf:Organization> </org:memberOf> </rdf:Description> </dct:creator> <dct:creator> <rdf:Description rdf:about="http://orcid.org/0000-0002-7143-6800"> <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/> <dct:identifier rdf:datatype="http://www.w3.org/2001/XMLSchema#string">0000-0002-7143-6800</dct:identifier> <foaf:name>David, Aliona</foaf:name> <foaf:givenName>Aliona</foaf:givenName> <foaf:familyName>David</foaf:familyName> <org:memberOf> <foaf:Organization> <foaf:name>2 Chiril Draganiuc Institute of Phthisiopneumology, Chisinau, the Republic of Moldova</foaf:name> </foaf:Organization> </org:memberOf> </rdf:Description> </dct:creator> <dct:creator> <rdf:Description rdf:about="http://orcid.org/0000-0002-0863-5268"> <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/> <dct:identifier rdf:datatype="http://www.w3.org/2001/XMLSchema#string">0000-0002-0863-5268</dct:identifier> <foaf:name>Botnaru, Victor</foaf:name> <foaf:givenName>Victor</foaf:givenName> <foaf:familyName>Botnaru</foaf:familyName> <org:memberOf> <foaf:Organization> <foaf:name>Nicolae Testemitanu State University of Medicine and Pharmacy Chisinau, the Republic of Moldova</foaf:name> </foaf:Organization> </org:memberOf> </rdf:Description> </dct:creator> <dct:title>Functional features in interstitial lung diseases</dct:title> <dct:publisher> <foaf:Agent> <foaf:name>Zenodo</foaf:name> </foaf:Agent> </dct:publisher> <dct:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#gYear">2020</dct:issued> <dcat:keyword>interstitial lung diseases</dcat:keyword> <dcat:keyword>pulmonary function tests</dcat:keyword> <dcat:keyword>obstruction</dcat:keyword> <dcat:keyword>restriction</dcat:keyword> <dct:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2020-11-01</dct:issued> <dct:language rdf:resource="http://publications.europa.eu/resource/authority/language/ENG"/> <owl:sameAs rdf:resource="https://zenodo.org/record/4018896"/> <adms:identifier> <adms:Identifier> <skos:notation rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://zenodo.org/record/4018896</skos:notation> <adms:schemeAgency>url</adms:schemeAgency> </adms:Identifier> </adms:identifier> <dct:isVersionOf rdf:resource="https://doi.org/10.5281/zenodo.4018895"/> <dct:description><p><strong>Background: </strong>Interstitial lung diseases (ILD) are a group of disorders that are generally thought to commonly share a restrictive ventilatory defect and reduced diffusing capacity for carbon monoxide (DLCO). The aim was to find distinctive features of the pulmonary function tests (PFT) results in different types of ILD.</p> <p><strong>Material and methods:</strong> We conducted a retrospective study of 40 consecutive patients with ILD admitted to the Institute of Pthisiopneumology, Chisinau, the Republic of Moldova, during January 2019 &ndash; February 2020. The cohort included 10 cases of sarcoidosis patients, 8 cases of idiopathic pulmonary fibrosis (IPF) patients, 7 patients with nonspecific idiopathic interstitial pneumonia, 9 cases with hypersensitivity pneumonitis (HP) and 6 histiocytosis cases. All patients have been evaluated by pulmonary function tests (PFT), 6 minutes walk test, Medical Research Council scale for dyspnea, etc.</p> <p><strong>Results: </strong>Overall, we found normal mean spirometry parameters, a slightly increased mean residual volume (127.5&plusmn;42.1), a mildly decreased mean total lung capacity (88.8&plusmn;22.3) and moderately reduced DLCO (52.6&plusmn;21.5). We found a dominant restrictive pattern in 75% of patients, and obstruction only in 7.5% when we used spirometry parameters. When we applied the bodyplethismographic values, we have found that an air-trapping pattern was identified in 32.5% cases of patients. This pattern has been identified in 1/3 of HP patients and in 10% of sarcoidosis patients.</p> <p><strong>Conclusions:</strong> PFT can help identifying individual features of different types of ILD being able to show even obstructive changes in a group of diseases thought to be strictly restrictive.</p></dct:description> <dct:accessRights rdf:resource="http://publications.europa.eu/resource/authority/access-right/PUBLIC"/> <dct:accessRights> <dct:RightsStatement rdf:about="info:eu-repo/semantics/openAccess"> <rdfs:label>Open Access</rdfs:label> </dct:RightsStatement> </dct:accessRights> <dct:license rdf:resource="https://creativecommons.org/licenses/by/4.0/legalcode"/> <dcat:distribution> <dcat:Distribution> <dcat:accessURL rdf:resource="https://doi.org/10.5281/zenodo.4018896"/> <dcat:byteSize>1752542</dcat:byteSize> <dcat:downloadURL rdf:resource="https://zenodo.org/record/4018896/files/MMJ-2020-63-5_9-14.pdf"/> <dcat:mediaType>application/pdf</dcat:mediaType> </dcat:Distribution> </dcat:distribution> </rdf:Description> </rdf:RDF>
All versions | This version | |
---|---|---|
Views | 19 | 19 |
Downloads | 14 | 14 |
Data volume | 24.5 MB | 24.5 MB |
Unique views | 19 | 19 |
Unique downloads | 14 | 14 |